demonstrated that myeloid cells suppress CD8+ T cells and antigen-presenting cells in the cervical cancer TME, thereby limiting the efficacy of immune responses against cancer and resulting in poor immunotherapy outcomes (70). This evidence concerns the gene CD8A and cancer.